Copyright
©The Author(s) 2017.
World J Radiol. May 28, 2017; 9(5): 245-252
Published online May 28, 2017. doi: 10.4329/wjr.v9.i5.245
Published online May 28, 2017. doi: 10.4329/wjr.v9.i5.245
Table 5 Adverse events
| Toxicity | Grade 1/2 | Grade 3/4 |
| Clinical findings | ||
| Post embolization syndrome | 11/73 (15%) | - |
| Ascites | 3/73 (4.1%) | - |
| Abdominal pain | 18/73 (24.6%) | - |
| Nausea/vomiting | 9/73 (12.3%) | - |
| Laboratory tests | ||
| Bilirubin | 5/73 (6.8%) | - |
| Transaminase | 10/73 (13.7%) | - |
- Citation: Greco G, Cascella T, Facciorusso A, Nani R, Lanocita R, Morosi C, Vaiani M, Calareso G, Greco FG, Ragnanese A, Bongini MA, Marchianò AV, Mazzaferro V, Spreafico C. Transarterial chemoembolization using 40 µm drug eluting beads for hepatocellular carcinoma. World J Radiol 2017; 9(5): 245-252
- URL: https://www.wjgnet.com/1949-8470/full/v9/i5/245.htm
- DOI: https://dx.doi.org/10.4329/wjr.v9.i5.245